SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs >

NorthWest Biotherapeutics (NWBO)

NWBO RSS Feed
Add NWBO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator TOB, Astavakra, Diamondjim61, TZOR, sentiment_stocks, Know-Fear
Search This Board:
Last Post: 8/27/2015 3:10:20 PM - Followers: 262 - Board type: Free - Posts Today: 43







 Stylized Dendritic Cell

A "personalized brain cancer vaccine, DCVAX, is the first of its kind and... is on the road to FDA approval."
- Neil A. Martin, Chairman, UCLA Department of Neurosurgery


Abstracts
"Clinical and immunopathological effects following Image-guided intratumoral injection of activated, autologous dendritic cells in patients with advanced solid cancers" - Abstract #2499 - AACR (American Association for Cancer Research)
"Proffered Paper:  Prolonged Survival for Patients with Recurrent Glioblastoma Multiforme who are Treated with Tumor Lysate-Pulsed Autologous Dendritic Cells" - presented at ITOC-Conference, Munich, Germany - March 26, 2015, 14:40 - Marnix Bosch, Chief Technical Officer, NW Bio (note, abstract linked here is from Science Direct)

Corporate Profile

NW Bio is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs.  NW Bio’s proprietary manufacturing technology enables them to produce its personalized vaccine in an efficient, cost-effective manner. NW Bio has a broad platform technology for DCVax dendritic cell-based vaccines.

Their lead product, DCVax-L, is currently in a 348-patient Phase III trial for patients with newly diagnosed Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer.  This trial is currently underway at 69 locations thoughout the United States, Germany and the United Kingdom. NW Bio has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania.

Their second product, DCVax-Direct, is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers, with trials currently being conducted at both MD Anderson Cancer Center in Texas, as well as Orlando Health in Florida.  

 They previously received clearance from the FDA for a 612-patient Phase III trial with its third product, DCVax-Prostate, for late stage prostate cancer.
 



Clinical Trials
DCVax®-L to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) - Phase III (Double Blind) 
Expanded Access Protocol for GBM Patients with Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 (NCT02146066) (Expanded Access)
Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) - Phase I/Phase II (Open Label)
UK Clinical Trials - Study of a Drug (DCVax®-L) to Treat Newly Diagnosed GBM Brain Cancer
EU Clinical Trials for DCVax-L - Phase III

Company Contact Info
Investor Relations:
Les Goldman    (Co.)     (202) 841-7909  lgoldman@nwbio.com
Farrell Kramer (Media)  (212) 710-9685  farrell.kramer@mbsvalue.com or media@nwbio.com

Company Headquarters
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814  (240) 497-9024

DCVAX Survival Stories
NWBO - Patients Sunday Dennis and Jami Newirth - Enrolled at UCLA - Vimeo, Uploaded approx. May 2015
NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015
NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson
NWBO GBM Brain Cancer Survival Story of Mark Pace
NWBO GBM Brain Cancer Suvivial Story of Brad Silver
NWBO, GBM Brain Cancer Survival Story of Mike Gregoire
UCLA - Real Stories Using DCVax

Designations & Awards
German Hospital Exemption (referred to as HE) Information for DCVax-L® - FIRST TIME EVER

DCVax-L Hospital Exemption Program Now Under Way in Germany (NWBO, PR Newswire, October 14, 2014)
Two German Approvals:  "Hospital Exemption" for Early Access Program with DCVax-L and Eligibility of DCVax-L for Reimbursement (NWBO, March 10 2104)
Analysis:  NWBO DCVax-L German Approval Under Hospital Exemption Early Access Program (Smith on Stocks, Nasdaq, March 11, 2014)
Exclusive - Germany OKs Northwest Bio Brain Cancer Drug, Shares Soar (Ransdell Pierson, Reuters, March 10, 2014)

FDA Endpoints & Approval Information
House committee approves bill to speed new drugs to market - May 21, 2015 (Toni Clarke, Reuters)
FDA could approve drugs fro new uses on less data:  draft law - April 29, 2015 (Toni Clarke, Reuters)
Richard Pazdur says FDA racing approvals due to unprecedented efficacy - April 15, 2015 (BioCentury TV)

United Kingdom Awards DC-Vax-L® as Promising Innovative Medicine (PIM) - FIRST TIME EVER
First UK "Promisting Innovative Medicine" Designation Awarded (Department of Health and George Freeman MP, Gov.UK, September 16, 2014)
NWBO's Cancer Vaccine is the First Drug to be Designated by UK Authorities as a "Promising Innovative Medicine" (PIM) - (NWBO, September 16, 2014)


Immunotherapy Index
Loncar Investments - Cancer Immunotherapy Index - follow how NWBO is weighted in this Index of 25 Immunotherapy Companies

Immunotherapeutic Niches, Competition and Collaboration (5 Parts)
Part III - Immunotherapeutic Niches, Competition and Collaboration. Immunomodulation - Anti-CTLA-4MAb (Prepared by flipper44, December 2014)
Part II - The Cellular Approach (Prepared by flipper44, November 2014)
Part I - Vaccines  (Prepared by flipper44, November 2014)

Interviews
Linda Powers Interview 5-15-12

Important or Helpful Links
NWBO Stock Quote & Information
NWBO SEC Filings
NWBO Twitter
NWBO Facebook
NWBO Yahoo Message Board

Upcoming Healthcare Conferences

Institutional Investments
Nearing "the finish line" on cancer vaccine trial, Maryland firm raises $40 million - April 3, 2015 (J.D. Harrison)
Northwest Biotherapeutics:  The $40 Million Woodford Financing is A Major Positive - April 3, 2105 (Smith on Stocks - Larry Smith)


NWBO Analysis
Northwest Biotherapeutics:  FDA Panel Recommendation to Approve Amgen's Cancer Vaccine is Hugely Significant In Regard to Possible Approval of DCVax-L and DCVax-Direct - May 1, 2015 (Smith on Stocks - Larry Smith)

Northwest Biotherapeutics:  Promising New Data Was Just Presented on DCVax-L in Recurrent Glioblastoma Mulitforme - March 27, 2015 (Smith on Stocks - Larry Smith)
Northwest Biotherapeutics:  How Much Will it Cost to Manufacture DcVax-L - March 5, 2015 (Smith on Stocks - Larry Smith)
The Potentially Key Role of Northwest Biotherapeutics in the Emerging Immuno-Oncology - February 3, 2105 (Smith on Stocks - Larry Smith)
Notes from Linda Powers Presentation in San Francisco - January 12, 2015 (Smith on Stocks - Larry Smith)
Current Investment Recommendations for Stocks Covered by SmithOnStocks; A Yearend Review - December 19, 2014 (Smith on Stocks - Larry Smith)
NWBO discussed at great length.
NWBO:  Putting Recent Clinical Data on DCVax Direct in Perspective - November 28, 2014 (Smith on Stocks - Larry Smith)
DCVax-L:  A Reimbursement Perspective - November 22, 2014 (Seeking Alpha - Ryan Pawell)
DCVax-Direct Validation and Updated DCVax-L Ph III Modeling - November 6, 2014 (Seeking Alpha - Steven Giardino [Pyrr])
Now is the Time for Northwest Biotherapeutics - October 29, 2014 (Seeking Alpha - Steven Giardino (Pyrr)
U.K. May Grant Early Patient Access for DCVax-L Priot to Formal Approval  - September 18, 2014 (Seeking Alpha - Larry Smith [Smith on Stocks])
Exciting News on Potential for Early Patient Access for DCVax-L in the UK - September 17, 2014 
(Larry Smith, Smith on Stocks)
The Data Monitoring Commitee Addresses the Status of the DCVax-L Trial - August 13, 2014 (Seeking Alpha - Larry Smith [Smith on Stocks])
Cancer Vaccines:  Northwest Biotherapeutics -vs- Dendreon - July 15, 2010 (M.E.Garza, BioMedReports)


NWBO News
NWBO Press Releases 
NWBO Yahoo Headlines

UK News Coverage
Cancer Treatments - Supplement in United Kingdom Times April 6, 2015
NW Bio Announces $40 Million Financing - Further Equity by Woodford Funds April 2, 2015
Woodford's new biotech could be the next Amgen November 26, 2014 (Gavin Lumsden, Citywire Money)
Neil Woodford invests £16m in brain cancer vaccine company November 19, 2014 (Ashley Armstrong, The Telegraph)

NWBO - Short Seller Rebuttals and Information
Washington Post - Pulitzer Prize Winning Steven Pearlstein addresses NWBO and Short Selling
Citizens for Responsibility and Ethics in Washington (CREW) Requests SEC Investigate Manipulation of Drug Company Stock Price to Benefit Short Sellers
My Dialogue with Adam Feuerstein on Northwest Biotherapeutics - September 25, 2014 (Larry Smith, Smith on Stocks)
Jim Cramer Explains How the Stock Market is Manipulated - sounds a bit like some of the techniques used here.


Patent Information
Espacenet Patent information for NWBO
Patentdocs - Patent applications for NWBO
JUSTIA Patents
NWBO Receives U.S. Patent on Broad Processes for Producing More Potent Dendritic Cells - March 18, 2013 
NWBO's Patent Portfolio is Further Expanded with Manufacturing Automation Patent - September 10, 2013
NWBO Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax Manufacturing - December 4, 2009
NWBO - Wikiinvest Intellectual Property - from the 10-K filed April 15, 2008

Patient Info
Prospective patients may contact NW Bio at patients@nwbio.com

Reports
Orphan Drug Report 2014  (EvaluatePharma, October 2014 - see page 14 ) 

Research Posters
AARC April 2015 - Prolonged Survival in Patients with Recurrent Glioblastoma Multiforme Who are Treated with Tumor Lysate-Pulsed Autologous Dendritic Cells
AARC April 2015 - Clinical and Immunopathological Effects Following Image-guided Intratumoral Injection of Activated, Autologous Dendritic Cells in Patients with Advanced Solid Cancers
SITC 2014 - Direct
ASCO 2014 - Direct

SEC Reports
Form 10-K - For fiscal year ended December 31, 2014

Stock Quote & Summary
As of May 6, 2015 

Common Shares Outstanding:   76,889,028
Options Outstanding:                   1,551,000
Convertible Notes:                       2,343,000
Share purchase warrants:          28,330,000

Total Fully Diluted Shares:       109,113,028


Beneficial Ownership of NWBO Common Stock held by: 
7.12% Security Holder – Toucan Partners, LLC:                         5,142,201 
37.95% Security Holder – Cognate BioServices:                      30,638,661
5.87% Security Holder – Dennis Mehiel:                                    4,125,949
11.23% Security Holder - Woodford Investment Management   7,896,675

Total (@12/31/14):                                                                     47,803,486 

Shares of common stock beneficially owned assumes the exercise of all options, warrants and other securities convertible into common stock beneficially owned by such person or entity currently exercisable or exercisable within 60 days of September 30, 2014.

52-Week High - (as of November 14) $10.64
52-Week Low - (as of  November 14)  $3.20

Transfer Agent:  BNYMellon Shareowner Services
520 Pike Street, Seattle, WA, 98101
Equity Holding customer service representatives are available from 9:00 a.m. to 7:00 p.m. Eastern Time,
Monday through Friday. Call +1 800 522 6645 (U.S. & Canada).

UCLA Department of Neurology
UCLA Chair of Neurosurgery Neil A. Martin, M.D., FAANS - Welcome Letter
DCVax in 4th paragraph - "on the road to FDA approval"

A Personal Quest to Cure Brain Cancer - (Into The Brain and Beyond by UCLA Neurosurgery)

Upcoming Events
Cancer Vaccines - September 16 to 17, 2015, London, UK.  Linda Powers to speak on "Novel Personalize Immune Therapies for Solid Tumors"

  • Ms. Powers will discuss NW Bio’s DCVax® platform technology, a personalized, dendritic cell based active immunotherapy for solid tumors.
     Unlike conventional cancer drugs and other immune therapies, which use one active agent to hit one target on the cancer, DCVax mobilizes many active agents of the immune system to hit many targets on the cancer.

     

SITC's 30th Anniversary Annual Meeting - November 4-8, 2015, National Harbor, MD  At this time, NWBO has a Presentation Booth at this meeting.  Updates will be made as they become available.  "Stay Tuned"
Current SITC Schedule Link


Webcasts
ASCO 2015 - Overview of DCVax Direct Phase 1 Trial - May 30, 2015 - Webcast by Marnix L. Bosch, MBA, PhD, CTO, NWBO (YouTube)
   Slides presented in ASCO presentation to accompany Video
NWBO Virtual Investor Conference - May 7, 2015 - Webcast by Linda Powers, CEO, NWBO (sign-up required)
NWBO Presentation at ITOC2 Conference - March 26, 2015 - Webcast by Marnix L. Bosch, MBA, PhD, CTO, NWBO (YouTube)
NWBO Presentation at BIO CEO & Investor Conference - February 9, 2015 - Webcast by Linda Powers
NWBO Presentation at Phacilitate Immunotherapy World 2015 - January 26, 2015 - Webcast by Linda Powers (YouTube)
Transcript of Biotech Showcase 2015 - from January 12, 2015 - provided by sentiment_stocks
NWBO- 25th Annual Oppenheimer Healthcare Conference - December 10, 2014 - accompanying Slide Show
Transcript of 25th Annual Oppenheimer Healthcare Conference - provided by RK (Includes Q&A at the end)
NWBO Linda Powers Presents at SMi 3rd Cancer Vaccines Conference 2014 - Linda announces England's 1st PIM (Promising Innovative Medicine) Designation and Recent Progress to Date and offers an excellent explanation of how DCVax works

Websites
NWBO Company Website
Wiki page for NWBO
Informative Investor Website
Immunology Acronyms

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NWBO
Current Price
Volume:
Bid Ask Day's Range
Wiki
NWBO News: NORTHWEST BIOTHERAPEUTICS ALERT: National Securities Law Firm Announces Filing of Lawsuit on behalf of Northwest Shareholders... 07:41 AM
NWBO News: Current Report Filing (8-k) 08/25/2015 09:16:29 AM
NWBO News: NORTHWEST BIOTHERAPEUTICS ALERT: National Securities Law Firm Announces Investigation of Potential Securities Claims, and Enc... 08/21/2015 04:07:00 PM
NWBO News: NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing 08/21/2015 03:22:00 PM
NWBO News: Quarterly Report (10-q) 08/10/2015 06:21:44 PM
News News Alert: NORTHWEST BIOTHERAPEUTICS ALERT: National Securities Law Firm Announces Filing of Lawsuit on behalf of Northwest Shareholders... 08/27/2015 07:41:00 AM
PostSubject
#39363  Sticky Note Biotech Stocks to bet on: Northwest Biotherapeutics, Inc Astavakra 08/25/15 10:30:19 PM
#38780  Sticky Note NW Bio Confirms Phase III Trial of DCVax®-L TOB 08/21/15 05:30:32 PM
#38034  Sticky Note This had to be posted already. Diamondjim61 08/03/15 03:15:59 PM
#30450  Sticky Note Forbes Article: Northwest Biotherapeutices Is a Best Idea sentiment_stocks 03/10/15 01:06:44 PM
#22663  Sticky Note SA Article: DCVax-Direct Validation and Updated DCVax-L Ph Pyrrhonian 11/06/14 04:17:55 PM
#39493   Great footwork. Then it still potentially fits flipper44 08/27/15 03:18:23 PM
#39492   Screening is halted everywhere. sentiment_stocks 08/27/15 03:10:20 PM
#39491   Good to see two German sites were added. flipper44 08/27/15 02:59:16 PM
#39490   It looks two new clinic were added in sentiment_stocks 08/27/15 02:40:57 PM
#39489   Yes Deja Vu - we have seen this CherryTree1 08/27/15 02:34:10 PM
#39488   Turns out your take is correct. sentiment_stocks 08/27/15 02:33:32 PM
#39487   I don't know why anyone except those that duderaja 08/27/15 02:31:52 PM
#39486   They put out those headlines so other organizations vator 08/27/15 02:29:13 PM
#39485   Can't stop Method B with Method Distract. vator 08/27/15 02:24:58 PM
#39484   Adam Fraudstein and his conspirators are at it CherryTree1 08/27/15 02:22:40 PM
#39483   Great point RK !!! Love it :) Turtle Go NWBO Turtle65 08/27/15 12:15:36 PM
#39480   Senti, catching up on IV messages. I read Rkmatters 08/27/15 11:57:46 AM
#39475   How ironic, how funny, I like it. Dan88 08/27/15 10:57:37 AM
#39473   Good point TC --- I agree with you !!! Turtle Turtle65 08/27/15 09:32:02 AM
#39472   I consider it unloading no matter what the TC_Trader 08/27/15 09:30:28 AM
#39471   Got my elephant gun out to buy 16k Turtle65 08/27/15 09:28:57 AM
#39470   10k shares is unloading ? I say thanks Turtle65 08/27/15 09:22:31 AM
#39469   I like honesty. I like integrity. I look Rkmatters 08/27/15 09:20:27 AM
#39467   RK in all NWBO presentation this year they DONOEVIL 08/27/15 09:07:12 AM
#39466   Pasting the 8-K filing and Exhibit 99.1. Rkmatters 08/27/15 08:54:55 AM
#39465   If anyone in these law firms would ever Papa Tweek1 08/27/15 08:37:29 AM
#39464   Someone is unloading shares this morning TC_Trader 08/27/15 08:19:16 AM
#39463   If NWBO replied stating that, the temporary halt DONOEVIL 08/27/15 07:50:15 AM
#39460   It is my opinion that NWBO rejects any Truthfan 08/27/15 07:24:26 AM
#39459   The exasperation on NWBOs part is almost palpable. antihama 08/27/15 06:53:38 AM
#39458   Below the accompanying letter. The trial is ongoing. staccani 08/27/15 06:52:58 AM
#39457   Look, I think you are pretty spot on vator 08/27/15 06:40:49 AM
#39456   It looks like more dirty tricks are at DoGood_DoWell 08/27/15 06:32:09 AM
#39455   I do not think there was any negotiations. staccani 08/27/15 06:23:49 AM
#39454   The last time at 66 for IA they vator 08/27/15 06:18:03 AM
#39453   SITC 2015 November 4-8 - NWBO in Booth TheFollower 08/27/15 06:17:50 AM
#39452   I think NWBO management should disclose why the staccani 08/27/15 04:53:29 AM
#39451   Since it is unknown what info the company Evaluate 08/27/15 12:39:08 AM
#39450   So we hire Michael Meehan a big PR jm100 08/26/15 10:18:02 PM
#39449   big veto. Rkmatters 08/26/15 10:13:43 PM
#39448   Got that right TC, that was my favorite Smokey21 08/26/15 09:30:56 PM
#39447   I received that on my bloomberg terminal too. TC_Trader 08/26/15 09:11:36 PM
#39446   Or it is simply serendipitous. flipper44 08/26/15 09:11:31 PM
#39445   Another ambulance chaser has come on board. JTORENCE 08/26/15 09:02:47 PM
#39444   Ah the common sense analysis! This is only TC_Trader 08/26/15 08:57:22 PM
#39443   It's been a crazy week to say the TC_Trader 08/26/15 08:54:06 PM
#39442   Even if they were at 300, it would Smokey21 08/26/15 08:36:08 PM
#39441   I hear you TZOR. I was watching Smokey21 08/26/15 08:19:46 PM
#39440   Ms. Powers will discuss NW Bio’s DCVax® platform TERIA 08/26/15 08:15:12 PM
#39439   RK, I absolutely agree with your read on Smokey21 08/26/15 07:57:57 PM
#39438   Hi TC. Anything interesting going on with the Ready4bluesky 08/26/15 07:49:21 PM
#39437   I would think you are right... sentiment_stocks 08/26/15 07:42:45 PM
#39436   Perhaps but they would never slow down the Reefrad 08/26/15 07:35:37 PM
#39435   The mention of children under "DCVax Product Markets" sentiment_stocks 08/26/15 07:31:50 PM
#39434   big veto. Reefrad 08/26/15 07:28:35 PM
PostSubject